Financials data is unavailable for this security.
View more
Year on year Youcare Pharmaceutical Group Co Ltd 's revenues fell -7.61% from 4.54bn to 4.20bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 335.01m to 184.80m, a -44.84% decrease.
Gross margin | 57.15% |
---|---|
Net profit margin | 2.45% |
Operating margin | 3.59% |
Return on assets | 1.65% |
---|---|
Return on equity | 2.66% |
Return on investment | 2.48% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Youcare Pharmaceutical Group Co Ltd fell by 144.81m. However, the company earned 785.49m from its operations for a Cash Flow Margin of 18.72%. In addition the company used 502.05m on investing activities and also paid 432.19m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.04 |
---|---|
Tangible book value per share | 7.02 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.82 |
---|---|
Quick ratio | 1.40 |
Total debt/total equity | 0.247 |
---|---|
Total debt/total capital | 0.1977 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -81.82% and -44.93%, respectively. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg) | 2.16% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 92.62% |
EPS growth(5 years) | -26.33 |
---|---|
EPS (TTM) vs TTM 1 year ago | -76.06 |
More ▼